ZA200204585B - Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties. - Google Patents
Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties.Info
- Publication number
- ZA200204585B ZA200204585B ZA200204585A ZA200204585A ZA200204585B ZA 200204585 B ZA200204585 B ZA 200204585B ZA 200204585 A ZA200204585 A ZA 200204585A ZA 200204585 A ZA200204585 A ZA 200204585A ZA 200204585 B ZA200204585 B ZA 200204585B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- obesity
- diabetic properties
- arylethanolamine derivatives
- arylethanolamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929297.1A GB9929297D0 (en) | 1999-12-11 | 1999-12-11 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200204585B true ZA200204585B (en) | 2003-12-31 |
Family
ID=10866125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200204585A ZA200204585B (en) | 1999-12-11 | 2002-06-07 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6548523B2 (enExample) |
| EP (1) | EP1235788B1 (enExample) |
| JP (1) | JP4903964B2 (enExample) |
| KR (1) | KR100683614B1 (enExample) |
| CN (1) | CN1224609C (enExample) |
| AT (1) | ATE292110T1 (enExample) |
| AU (1) | AU769387B2 (enExample) |
| BR (1) | BRPI0016187B1 (enExample) |
| CA (1) | CA2394117C (enExample) |
| CZ (1) | CZ303143B6 (enExample) |
| DE (1) | DE60019157T2 (enExample) |
| ES (1) | ES2236020T3 (enExample) |
| GB (1) | GB9929297D0 (enExample) |
| HK (1) | HK1045988B (enExample) |
| HU (1) | HU229043B1 (enExample) |
| IL (1) | IL149585A0 (enExample) |
| NO (1) | NO323239B1 (enExample) |
| NZ (1) | NZ518795A (enExample) |
| PL (1) | PL200540B1 (enExample) |
| PT (1) | PT1235788E (enExample) |
| TR (1) | TR200201528T2 (enExample) |
| WO (1) | WO2001042195A1 (enExample) |
| ZA (1) | ZA200204585B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10230147A1 (de) * | 2001-10-09 | 2004-01-15 | Profos Ag | Verfahren zur unspezifischen Anreicherung von Bakterienzellen |
| US7158049B2 (en) * | 2003-03-24 | 2007-01-02 | Schlumberger Technology Corporation | Wireless communication circuit |
| US8213085B2 (en) * | 2008-01-18 | 2012-07-03 | Visera Technologies Company Limited | Image sensor device with high photosensitivity |
| US8778998B2 (en) | 2009-04-10 | 2014-07-15 | Auspex Pharmaceuticals, Inc. | Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
| EA030145B1 (ru) | 2010-08-03 | 2018-06-29 | Велисепт Терапьютикс, Инк. | Комбинации агонистов бета-3-адренергических рецепторов и антагонистов мускариновых рецепторов для лечения гиперактивности мочевого пузыря |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| CA2864173A1 (en) | 2012-02-09 | 2013-08-15 | Altherx, Inc. | Combination of muscarinic receptor antagonists and beta-3 adrenoceptor agonists for treating overactive bladder |
| EP3226849A4 (en) | 2014-12-03 | 2018-05-09 | Velicept Therapeutics, Inc. | Compositions and methods of using modified release solabegron for lower urinary tract symptoms |
| FI3365321T3 (fi) | 2015-10-23 | 2024-01-02 | B3Ar Therapeutics Inc | Solabegron-Zwitterioni ja sen käyttöjä |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1551260A (en) * | 1976-02-09 | 1979-08-30 | Allen & Hanburys Ltd | Phenylethanolamine derivatives |
| JP2577222B2 (ja) * | 1987-04-10 | 1997-01-29 | 興和株式会社 | 新規な置換アニリド誘導体 |
| NO179246C (no) | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| GB9525121D0 (en) * | 1995-12-08 | 1996-02-07 | Glaxo Group Ltd | Chemical compounds |
| WO1999057098A2 (en) * | 1998-05-01 | 1999-11-11 | Abbott Laboratories | Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
-
1999
- 1999-12-11 GB GBGB9929297.1A patent/GB9929297D0/en not_active Ceased
-
2000
- 2000-12-08 WO PCT/GB2000/004697 patent/WO2001042195A1/en not_active Ceased
- 2000-12-08 AT AT00985495T patent/ATE292110T1/de active
- 2000-12-08 BR BRPI0016187A patent/BRPI0016187B1/pt not_active IP Right Cessation
- 2000-12-08 CN CNB008170177A patent/CN1224609C/zh not_active Expired - Fee Related
- 2000-12-08 CZ CZ20022017A patent/CZ303143B6/cs not_active IP Right Cessation
- 2000-12-08 JP JP2001543497A patent/JP4903964B2/ja not_active Expired - Fee Related
- 2000-12-08 AU AU21911/01A patent/AU769387B2/en not_active Ceased
- 2000-12-08 EP EP00985495A patent/EP1235788B1/en not_active Expired - Lifetime
- 2000-12-08 KR KR1020027007383A patent/KR100683614B1/ko not_active Expired - Fee Related
- 2000-12-08 ES ES00985495T patent/ES2236020T3/es not_active Expired - Lifetime
- 2000-12-08 PL PL356483A patent/PL200540B1/pl unknown
- 2000-12-08 HU HU0203640A patent/HU229043B1/hu not_active IP Right Cessation
- 2000-12-08 HK HK02107499.9A patent/HK1045988B/en not_active IP Right Cessation
- 2000-12-08 US US10/148,841 patent/US6548523B2/en not_active Expired - Lifetime
- 2000-12-08 NZ NZ518795A patent/NZ518795A/en unknown
- 2000-12-08 DE DE60019157T patent/DE60019157T2/de not_active Expired - Lifetime
- 2000-12-08 IL IL14958500A patent/IL149585A0/xx not_active IP Right Cessation
- 2000-12-08 TR TR2002/01528T patent/TR200201528T2/xx unknown
- 2000-12-08 PT PT00985495T patent/PT1235788E/pt unknown
- 2000-12-08 CA CA2394117A patent/CA2394117C/en not_active Expired - Fee Related
-
2002
- 2002-06-07 ZA ZA200204585A patent/ZA200204585B/xx unknown
- 2002-06-10 NO NO20022758A patent/NO323239B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG101250A (en) | Salts of an anti-migraine indole derivative | |
| HU0101336D0 (en) | Process for the preparation of perindopril and their pharmaceutically acceptable salts | |
| IL157816A0 (en) | Steroids as agonists for fxr | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| GB9914486D0 (en) | Medicaments | |
| CY1106743T1 (el) | Μεθοδος παρασκευης θειαμεθοξαμης | |
| GR3037080T3 (en) | Naphthalene derivatives as prostaglandin i2 agonists | |
| SE9203825L (sv) | Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma | |
| MXPA05009668A (es) | Proceso libre de azida para preparar compuestos de 1,2-diamino. | |
| ATE230740T1 (de) | Piperidinylpyrimidine derivate | |
| WO2002072009A3 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
| YU7804A (sh) | Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova | |
| NZ334954A (en) | Substituted heterocycles as anti-tumor agents | |
| ZA200204585B (en) | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties. | |
| GB0109122D0 (en) | Novel compounds | |
| MY138826A (en) | 2,7-substituted indoles | |
| IL108695A (en) | Pharmaceutical composition comprising polyamine derivatives and some such novel compounds | |
| AU2001260445A1 (en) | Triterpenoid derivatives | |
| MXPA01011955A (es) | Aminoacidos policiclicos, fusionados, como agentes farmaceuticos. | |
| IL113341A0 (en) | Pharmaceutical compositions comprising antimigraine compounds and their preparation | |
| EP1445262A8 (en) | Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof | |
| AU2001258631A1 (en) | Triterpenoid derivatives | |
| MX9500363A (es) | Monohiddrato de (e)-2'-desoxi-2'- (fluorometilen) citidina. | |
| BG105999A (en) | Treatment of osteoarthritis | |
| WO2002042261A8 (en) | PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES |